| Nasopharyngeal carcinoma YP Chen, ATC Chan, QT Le, P Blanchard, Y Sun, J Ma The Lancet 394 (10192), 64-80, 2019 | 2368 | 2019 |
| Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis P Blanchard, A Lee, S Marguet, J Leclercq, WT Ng, J Ma, ATC Chan, ... The lancet oncology 16 (6), 645-655, 2015 | 773 | 2015 |
| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site P Blanchard, B Baujat, V Holostenco, A Bourredjem, C Baey, J Bourhis, ... Radiotherapy and oncology 100 (1), 33-40, 2011 | 767 | 2011 |
| Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open … J Bourhis, C Sire, P Graff, V Grégoire, P Maingon, G Calais, B Gery, ... The lancet oncology 13 (2), 145-153, 2012 | 436 | 2012 |
| Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy … P Blanchard, J Bourhis, B Lacas, MR Posner, JB Vermorken, ... Journal of clinical oncology 31 (23), 2854-2860, 2013 | 368* | 2013 |
| Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis B Lacas, J Bourhis, J Overgaard, Q Zhang, V Grégoire, M Nankivell, ... The Lancet Oncology 18 (9), 1221-1237, 2017 | 352 | 2017 |
| What is the best treatment of locally advanced nasopharyngeal carcinoma? An individual patient data network meta-analysis L Ribassin-Majed, S Marguet, AWM Lee, WT Ng, J Ma, ATC Chan, ... Journal of Clinical Oncology 35 (5), 498-505, 2017 | 339 | 2017 |
| Prevalence and causes of burnout amongst oncology residents: a comprehensive nationwide cross-sectional study P Blanchard, D Truchot, L Albiges-Sauvin, S Dewas, Y Pointreau, ... European journal of cancer 46 (15), 2708-2715, 2010 | 314 | 2010 |
| Brachytherapy: An overview for clinicians C Chargari, E Deutsch, P Blanchard, S Gouy, H Martelli, F Guérin, ... CA: a cancer journal for clinicians 69 (5), 386-401, 2019 | 285 | 2019 |
| Treatment de‐escalation in HPV‐positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives H Mirghani, F Amen, P Blanchard, F Moreau, J Guigay, DM Hartl, ... International journal of cancer 136 (7), 1494-1503, 2015 | 274 | 2015 |
| Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma CR Peeler, D Mirkovic, U Titt, P Blanchard, JR Gunther, A Mahajan, ... Radiotherapy and Oncology 121 (3), 395-401, 2016 | 270 | 2016 |
| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group B Lacas, A Carmel, C Landais, SJ Wong, L Licitra, JS Tobias, B Burtness, ... Radiotherapy and Oncology 156, 281-293, 2021 | 260 | 2021 |
| Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer–a case matched analysis P Blanchard, AS Garden, GB Gunn, DI Rosenthal, WH Morrison, ... Radiotherapy and Oncology 120 (1), 48-55, 2016 | 237 | 2016 |
| Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement DJ Thomson, D Palma, M Guckenberger, P Balermpas, JJ Beitler, ... International Journal of Radiation Oncology* Biology* Physics 107 (4), 618-627, 2020 | 232 | 2020 |
| Treatment de-escalation for HPV-driven oropharyngeal cancer: where do we stand? H Mirghani, P Blanchard Clinical and translational radiation oncology 8, 4-11, 2018 | 196 | 2018 |
| A randomized trial of induction docetaxel–cisplatin–5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02) M Frikha, A Auperin, Y Tao, F Elloumi, N Toumi, P Blanchard, P Lang, ... Annals of Oncology 29 (3), 731-736, 2018 | 180 | 2018 |
| Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: first comparative results of patient-reported outcomes TT Sio, HK Lin, Q Shi, GB Gunn, CS Cleeland, JJ Lee, M Hernandez, ... International Journal of Radiation Oncology* Biology* Physics 95 (4), 1107-1114, 2016 | 169 | 2016 |
| Intensity modulated proton therapy (IMPT)–The future of IMRT for head and neck cancer AC Moreno, SJ Frank, AS Garden, DI Rosenthal, CD Fuller, GB Gunn, ... Oral oncology 88, 66-74, 2019 | 168 | 2019 |
| Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients V Mallet, P Blanchard, V Verkarre, A Vallet-Pichard, H Fontaine, ... Aids 21 (2), 187-192, 2007 | 156 | 2007 |
| Hyperfractionated or accelerated radiotherapy for head and neck cancer B Baujat, J Bourhis, P Blanchard, J Overgaard, KK Ang, M Saunders, ... Cochrane Database of Systematic Reviews, 2010 | 154 | 2010 |
Philippe GorpheGustave RoussyAdresse e-mail validée de gustaveroussy.fr
